Skip to content

Programming Aquatic Therapy for POTS

Programming Aquatic Therapy for POTS

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07182578
Enrollment
5
Registered
2025-09-19
Start date
2025-09-12
Completion date
2026-02-08
Last updated
2026-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postural Orthostatic Tachycardia Syndrome (POTS)

Keywords

Aquatic Therapy, Occupational therapy, POTS, Postural Orthostatic Tachycardia Syndrome, Dysautonomia, Rehabilitation, Hydrotherapy

Brief summary

The goal of this pilot study is to create, implement, and evaluate an aquatic therapy for Postural Orthostatic Tachycardia Syndrome (POTS) program feasibility and ability to improve quality of life as determined by reduced orthostatic tachycardia, reduced POTS symptoms, and improved quality of life measures. The main questions it aims to answer are: Does aquatic occupational therapy reduce orthostatic tachycardia and POTS symptoms? Does aquatic occupational therapy lead to higher quality of live measures for people with POTS? Is this aquatic occupational therapy program feasible for clinicians and people with POTS? There is no comparison group for this pilot study. Participants will complete: An occupational Therapy evaluation before and after program completion (3 hours total) 30 minutes at home/remote 30 minutes on-site/in-person 30 minutes of individualized occupational therapy on land Participate in 3 aquatic therapy sessions per week, 60 minutes each for 12 weeks

Interventions

Aquatic Occupational Therapy sessions will be 60 minutes long, with 45 minutes spent in the pool. Sessions will include a gentle floating, stretching, or aqua yoga warm-up and an ai chi cooldown. Exercises in the first month will include a focus on balance, breathing, and sensory work. Exercises in the second month will focus on building strength and endurance, while the third month will combine all of the above with dual-task completion. Activities will be graded down (made less difficult) or graded up (made more challenging) according to individual participant needs.

Sponsors

California State University, Dominguez Hills
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed with POTS, Age 18-64, Participants must be English speaking, participants must obtain a physician permission letter\* \* The physician letter will only state that the participant is cleared to participate in aquatic therapy, it will not confirm or state what disease the individual has in the medical records or other HIPAA information.

Exclusion criteria

* Not diagnosed with POTS, Not between the ages of 18-64\*, Epilepsym Bowel incontinence \*The reason for the age requirement is because individuals: * under 18 have different diagnostic criteria and mechanisms for POTS than the age range specified and may respond differently to treatment * over age 65 have different mechanisms behind POTS than younger individuals, and frequently have health conditions or factors that can be difficult to differentiate from POTS symptoms/diagnosis and would require lab work and continuous physician involvement. POTS is less common in older adults. * The typical age of onset for POTS is generally considered to be between the ages of 15-50 years of age * For participant's safety, the researcher needs to be able to communicate with them in the aquatic setting. English is the researcher's only language and electronic translators are not accessible/usable in the pool setting.

Design outcomes

Primary

MeasureTime frameDescription
Composite Autonomic Symptom Score-31From enrollment to the end of 12 weeks of aquatic occupational therapy intervention.Measures neurodegenerative system symptoms through 31 patient-reported questions. Assessment is through six weighted domains: orthostatic intolerance \[10 points\]; vasomotor \[6 points\]; secretomotor \[7 points\]; gastrointestinal \[28 points\]; bladder \[9 points\] and pupillomotor \[15 points\]. A higher score indicates worse autonomic dysfunction. Simple yes or no questions are scored as 0 points for no and 1 point for yes. Questions about a specific site of symptoms or symptoms under specific circumstances are scored as 0 if not present and as 1 if present for each site or circumstance. All questions regarding the frequency of symptoms were scored as 0 points for rarely or never, 1 point for occasionally or sometimes, 2 points for frequently or "a lot of the time," and 3 points for almost always or constantly. All questions regarding the severity of symptoms were scored as 1 point for mild, 2 points for moderate, and 3 points for severe. The measure will be reported as a COMPASS score
Malmo POTS Scale (MAPS)From enrollment to the end of 12 weeks of aquatic occupational therapy interventionThis 12-item questionnaire assesses the specific POTS symptom burden over the past 3 months. Each question uses a visual analog scale from 0-10, with a maximum score of 120. A score of 42 or higher is considered indicative of POTS. The measure will be reported as a MAPS score.
ADLS, IADLS, and Vestibular QuestionnaireFrom enrollment to the end of 12 weeks of aquatic occupational therapy interventionThis is a 26-item questionnaire that will be filled out digitally. 21 questions cover about to participate in occupations listed in the Occupational Therapy Practice Framework using a scale from 1-10, where 1 is unable to complete the task, 5 is able to complete task with moderate difficulty (noticeable symptoms and extra effort is required) 10 is no problems/symptoms completing the task. It also contains 5 vestibular related questions using a scale from 1-7, with 1 being not at all dizzy, 4 being moderately dizzy, and 7 being extremely dizzy. The measure will be reported as an AIVQ score.
Active Stand TestFrom enrollment until the end of treatment at 12 weeksThe patient will begin laying down in a relaxed and comfortable position. Blood pressure (BP) and heart rate (HR) are taken after 5 minutes. Next, the patient will be asked to stand promptly, and will have their BP and HR measured immediately. The therapist will note any comments like "feeling dizzy". The BP and HR will be taken again and documented after three minutes, and again after ten minutes of standing. If there is any event, such as severe dizziness, paleness, etc, the BP and HR will be taken and documented just before the patient sits down. The measure will be reported as the position, time, and the correlated heart rate and blood pressure.
Single leg stance testFrom enrollment to the end of 12 weeks of aquatic occupational therapy interventionThis test measures a person's ability to balance standing on one leg without assistance. The participant will stand on one leg with their hands on their hips while being timed. The test is repeated 3 times for each leg and averaged. The measure will be reported as time standing per leg.
Heart RateFrom enrollment to the end of treatment at 12 weeksHeart rate (HR) will be measured on land while the participant is laying down, sitting up, and standing. HR in the water will be taken while seated and standing. An aquatic HR maximum and HR zones will be calculated for each participant. This measure will be reported as a land-based and aquatic HR maximum.
Borg's rate of perceived exertion scaleFrom enrollment to the end of treatment at 12 weeksThis scale is used to tell how tiring an activity feels. The scale ranges from 6 (no exertion at all), to 20 (maximal heaviness). This will be reported as the RPE score.
World Health Organization Quality of Life - Brief (WHOQOL-BREF)From enrollment to the end of 12 weeks of aquatic occupational therapy interventionThe WHOQOL-BREF is a 26-item questionnaire that will be completed digitally. It is scored by first assigning numerical values (1-5) to each response, with higher scores generally indicating a better quality of life. Then, raw domain scores are calculated by averaging the responses within each domain (Physical, Psychological, Social, and Environmental). Finally, these raw domain scores are transformed into scaled scores ranging from 0 to 100 by multiplying by 4. Higher scores on the 0-100 scale indicate a higher quality of life. The measure will be reported as a quality of life score.
The DePaul Symptom Questionnaire (Short Form) (DSQ-SF)From enrollment to the end of 12 weeks of aquatic occupational therapy intervention.14-item-questionnaire which measures post-exertional malaise symptoms over the last 6 months. Each question requires two ratings, one for frequency (0 = none of the time and 4 = all of the time) and one for severity (0 = symptom not present and 4 = very severe). A frequency of at least 2 and a severity of at least 2 on any one of the 5 questions on the DSQ-SF subscale indicate that post exertional malaise is present. For each symptom, the frequency and severity scores are averaged, and then multiplied by 25 to create a composite score out of 100. The measure will be reported as a post exertional malaise score.

Secondary

MeasureTime frameDescription
The Stroop TestFrom enrollment to the end of 12 weeks of aquatic occupational therapy interventionThe Stroop Test is a measure of working memory and attention. A participant is asked to read words of various colors, say the color of the letters when they are the same, and when the colors don't match the words. They are timed and errors are tracked. This will be reported as the SCWT score.
EnrollmentFrom enrollment to the end of treatment at 12 weeksTotal number of participants who complete the informed consent, evaluation session, and agree to participate in program according to schedule discussed with participant
Trail Making Test Parts A & BFrom enrollment to the end of the intervention at 12 weeksThe participant is given a paper with numbers and letters, and is instructed to connect the letters and numbers in order (1-A-2-B-3-C, etc.), as quickly as possible, without lifting the pend or pencil from the paper. Errors will be pointed out immediately and the participant is allowed to correct it, but the time it takes to correct is still included in the completion time for the task. This will be reported as the TMT-A and TMT-B scores.
Attrition RateFrom enrollment to the end of treatment at 12 weeksThe number of enrolled participants who do not complete the program
Session attendance rateFrom enrollment to the end of treatment at 12 weeksThis will be calculated by the number of sessions attended out of the total number of sessions for the program.
Cost analysisFrom enrollment to the end of treatment at 12 weeksThis measure will include resource tracking and total costs divided by the number of completers.
Health utilization changesFrom enrollment to the end of treatment at 12 weeksThis will include a calculation of health utilization changes from before the program compared to after the program
Satisfaction AnalysisFrom enrollment to the end of treatment at 12 weeksThematic analysis of open-ended feedback from participants and stakeholders will determine the most common themes and areas for improvement within the program.
Exercise self-efficacyFrom enrollment to the end of treatment at 12 weeksMeasure will be completed before the program and compared to the result after, leading to an ESE score.
Goal Attainment ScalingFrom enrollment to the end of treatment at 12 weeksGoal attainment scaling is a method to turn individualized goals into a 5-point evaluation method, using a score of -2 to + 2 to quantify progress towards the specific goals. It measures the outcomes against expected results, where 0 is the expected outcome, -2 is much less than the expected outcome, and +2 is much more than the expected outcome.
Beighton ScoreFrom enrollment to the end of treatment at 12 weeksThe Beighton score is a screener for hypermobility and can be done quickly and simply with no testing materials needed. It consists of a 5-point scale, requires 5 maneuvers. It involves the evaluation of only a small number of joints, so any hypermobile joints not in this group may be overlooked.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATOREvaRose Celeste, OT Doctoral student

California State University, Dominguez Hills

STUDY_CHAIRTracy Becerra-Culqui, PhD, MPH, BS OT

California State University, Dominguez Hills

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 4, 2026